Markets

Company News For Sep 6, 2017

  • Shares of Insmed Inc. INSM surged 120% after the company announced that it had completed the study of NTM lung disease and would now seek priority review and approval
  • Celectis S.A.'s CLLS shares dropped 20% after the Food and Drug Administration ordered the drug company to stop its cancer-drug trial immediately
  • HB Fuller's FUL shares surged 2.5% after it entered into an agreement to purchase Royal Adhesives & Sealants for $1.58 billion
  • Shares of Alphabet Inc. GOOGL tumbled 1.1% after news broke out that the European Commission could levy a record fine on the company's Google unit

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Alphabet Inc. (GOOGL): Free Stock Analysis Report

H. B. Fuller Company (FUL): Free Stock Analysis Report

Insmed, Inc. (INSM): Free Stock Analysis Report

Cellectis S.A. (CLLS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GOOGL FUL CLLS INSM

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More